PregLem is formerly owned by Sofinnova Partners, through Sofinnova Capital VI, since 2006.

When did Sofinnova Partners acquire PregLem?

Sofinnova Partners acquired PregLem in 2006 and exited after 4 years.

Has PregLem been sold?

Yes. PregLem was exited in 2010 via Trade Sale.

Home/Companies/Biotech/PregLem

PregLem

Biotech·

Switzerland·Exited 2010·Held 4yr

PregLem is a healthcare / biotech company, headquartered in Switzerland.

Entry

2006

Hold

4yr

Exit

2010

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQSwitzerland

SectorHealthcare / Biotech

Swiss specialty biopharma developing drugs for women's health including esmya for uterine fibroids, acquired by Richter Group in 2010.…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Sofinnova Capital VI

Other portfolio companies in the same fund.

Omthera Pharmaceuticals

Exited 2013

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings